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A B S T R A C T
This paper illustrates the need for human biologists to take into account the far-rea-
ching influences of biomedicine in the study of reproductive aging. Data were drawn
from western Massachusetts and Puebla, Mexico, to illustrate the effects of hysterectomy
rates, tubal ligations and hormone replacement therapy (HRT) on studies of age and
symptom experience at menopause. First, in examining age at natural menopause in re-
lation to level of education, a country-specific, non-random pattern of participant exclu-
sion due to hysterectomies was encountered. Second, in examining symptom frequency
in relation to late childbearing, sample sizes were very small in part due to a high fre-
quency of tubal ligations (43%) in Puebla, Mexico. Third, hot flash frequency during the
two weeks prior to interview was, unexpectedly, not lower among women who used HRT.
Human biologists who study the biological process of reproductive aging must also at-
tend to the cultural influences of biomedicine.
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Introduction
The broad aim of this paper is to call
attention to ways in which human biolo-
gists who study the biological process of
reproductive aging must also attend to
the cultural influences of biomedicine.
The focus of this paper is on the study of
age and symptom experience at meno-
pause and how the ability to ask or an-
swer questions is potentially affected by
three common and culturally appropriate
medical interventions in the lives of stu-
dy participants: hysterectomies, tubal li-
gation, and hormone replacement ther-
apy (HRT). First, age at menopause is
examined in relation to level of education.
In doing so, a non-random pattern of par-
ticipant exclusion due to hysterectomies
is encountered. Second, symptom fre-
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quency is examined in relation to late
childbearing, and unexpectedly high fre-
quencies of tubal ligation decrease sam-
ple sizes. Third, symptom frequency is ex-
amined in relation to use of hormone re-
placement therapy, with unexpected re-
sults.
Menopause is generally defined as the
cessation of menstruation followed by
twelve months of amenorrhea1. The ces-
sation of menstruation is the result of the
exhaustion of ovarian follicles2 to a point
below which menstrual cycles cannot be
maintained3,4. Loss of fertility precedes
the last menstrual period4–6; however, for
many women, menopause functions as
the first and final visible confirmation of
fertility's end. Thinking about menopau-
se as the cessation of both menstruation
and fertility allows for a fuller examina-
tion of the effects of medicalization on
studies of age and symptom experience at
menopause.
The concept of medicalization refers to
the process whereby aspects of everyday
life come under medicine's supervision
and influence7,8. Through medicalization,
the labels 'healthy' and 'ill' are applied to
aspects of human experiences that had
previously been outside of medicine's do-
main9. Medicalization extends the bound-
aries of medicine by defining experiences
in medical terms and by »treating« condi-
tions through medical intervention10. Ex-
amples of medicalization include the me-
dical management of universal, non-di-
sease events (birth, menopause), deviant
behavior (compulsive gambling, hyperac-
tivity), social problems (child abuse, do-
mestic violence), physical changes associ-
ated with maturation (teenage acne), aging
(hair loss), and hormonal cycles (premen-
strual syndrome).
The medicalization of female fertility
is a broad topic of concern, blanketing the
medicalization of pre-pregnancy11, infer-
tility12,13, reproductive decision-making14,
prenatal care15, and childbirth16,17. The
medical management of menopause has
been a particularly common focus of the
critiques of medicalization18–32.
In general, the process of medicali-
zation has not been of academic concern
to human biologists. Nonetheless, the me-
dicalization of female fertility does affect
the ability of human biologists to ask or
answer questions about variability in age
and symptom experience at menopause.
Hysterectomies, tubal ligation, and HRT
are all means by which aspects of female
fertility are medically managed.
Hysterectomies are biomedical treat-
ments for leiomyoma (fibroids), abnormal
uterine bleeding, endometriosis, uterine
prolapse, and gynecological malignancies.
Unnecessary hysterectomies are, at times,
carried out when women seek medical ad-
vice for heavy bleeding that could be ma-
naged by other, less invasive, treatments.
The evidence for this includes cross-coun-
try differences in rates of hysterecto-
mies33, variation in hysterectomy rates
across geographic regions within the
United States34–36, and elevated rates of
hysterectomy among women with lower
levels of education, occupational status
and income levels37–41, previous tubal li-
gation42,43, insurance coverage35,44, and the
ability to speak English45.
Medicalization, an interactive process
in which patients participate10,20,46,47, can
explain part of the variation in hysterec-
tomy rates. The treatment of heavy bleed-
ing by hysterectomy demonstrates the ex-
tent to which women are willing to go
along with a surgical solution. In Mexico,
women and their physicians have also
used hysterectomies as a method of birth
control45. Another aspect of medicaliza-
tion is the definition of the uterus as un-
necessary once childbearing is complete.
As expressed by a study participant in
Puebla, »When he took out my uterus, the
doctor told me »sirve para la vida, pero
despues no sirve para nada (it gives life,
but afterwards does nothing).« This atti-
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tude may, in part, explain why women
with a history of tubal ligation are more
likely to undergo a hysterectomy42,43.
Rates of hysterectomies are of interest
to human biologists because the exclu-
sion of women with hysterectomies from
analyses of age at natural menopause re-
duces sample sizes. To demonstrate this
effect, the first aim of this paper is test
the hypothesis that age at menopause dif-
fers by level of education in western Mas-
sachusetts and Puebla. One point that
immediately becomes apparent is that,
with respect to level of education, hyster-
ectomies are not random39.
In Mexico, the rate of tubal ligation
(ligadura de trompas) among women who
use birth control is 41.3%48. Tubal liga-
tion is a medicalized form of birth control
because only a physician can perform a
tubal ligation. Although ostensibly a birth
control choice, the choice of tubal ligation
is complicated by cultural, political and
economic contexts. For example, Lopez14
points out that, »Puerto Rican women be-
came predisposed to sterilization because
of its widespread availability and conve-
nience, social acceptance, and overall lack
of viable options« (p.243). Among its ad-
vantages in Mexico, the method allows
women and their physicians to limit fer-
tility without a husband's knowledge.
Rates of tubal ligation are of interest
to human biologists who study menopau-
se because tubal ligations, like natural
menopause, bring about the permanent
cessation of fertility. Tubal ligations can
be understood to be a form of »cultural
menopause«49,50. Of concern to this paper,
the curtailment of fertility before the on-
set of natural menopause limits some of
the questions that can be asked about
symptom experience. One of the original
aims of the Puebla study was to test the
hypothesis that hot flashes are less fre-
quently reported by women who give
birth and lactate into the early years of
peri-menopause. This hypothesis was de-
rived from the argument that, when
menopause occurs within the hormonal
context of lactation, unpleasant symp-
toms caused by fluctuations in circulating
hormones may be masked or modified by
the continuous presence of prolactin and
oxytocin51. The point that became obvious
in preliminary analyses was that, in part
because of the high frequency of tubal li-
gations in Mexico, few women gave birth
after 35 years of age.
HRT has become increasingly common
in the United States29,52, as well as in
parts of Europe53 and Latin America. Much
has been written about the medicaliza-
tion of menopause since the widespread
availability of HRT20,26,29,32. In addition to
decreasing the risk of osteoporosis18,27,32,
HRT decreases the severity of hot fla-
shes54. Therefore, to demonstrate the ef-
fect of HRT on the study of menopause,
the third aim of this paper is simply to
test the hypothesis that women who use
HRT report fewer hot flashes in western
Massachusetts and Puebla.
Sample and Methods
In western Massachusetts, the sample
of women aged 40–60 was recruited over
a period of seven years (1994–2001) from
school districts, a shopping mall, commu-
nity groups, a chiropractic office, a Breast
Health Project, and an OB/GYN office.
Site of recruitment was not significantly
associated with symptom frequency and,
in contrast to conventional wisdom, wo-
men recruited from the OB/GYN office
(n=50) reported fewer hot flashes com-
pared to women recruited from commu-
nity sites55. A total of 349 women partici-
pated in the initial interviews. Of these,
299 participated in anthropometric mea-
sures at interview and 257 (74%) retur-
ned an additional survey by mail. Fifty
continue to participate in follow-up inter-
views. In the city of Puebla, data were
collected from June 1999 through August
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2000. Women aged 40–60 were recruited
for interviews from public parks, on the
streets outside of their homes, in open
markets, at bus stops, in small shops, and
in front of large public buildings such as
the Social Security hospital. Interviews
and anthropometric measures conducted
on the spot or at a later appointment,
lasted from 30 minutes to more than one
hour. The entire city was canvassed to
achieve a sample (n=755) with represen-
tation from all social classes (see Table 1
for sample characteristics).
To test the hypothesis that age at me-
nopause differs by level of education in
western Massachusetts and Puebla, edu-
cation was divided into three categories
(low, medium, and high). Mean level of
education was almost twice as high in
Massachusetts (15.2 years, SD=2.5) as in
Puebla (8.1 yrs., SD=4.4). Therefore, lev-
els of education in Massachusetts were
divided into population-specific catego-
ries of 8–12 years (n=50), 13–16 years
(n=133), and 17–22 years (n=73). Levels
of education in Puebla, were divided into
population-specific categories of 0–6 years
(n=381), 7–12 years (n=295), and 13–25
years (n=76).
Age at menopause was determined as
age at last menstrual period (followed by
12 months of amenorrhea). To avoid in-
cluding women who experienced a prema-
ture ovarian failure, and to follow the
convention applied most frequently in de-
veloped countries, only women with a na-
tural menopause over age 39 were in-
cluded in the analyses that follow. This
excluded three women from the Massa-
chusetts sample and 21 women from the
Mexican sample. Analysis of variance was
applied to evaluate differences in mean
ages at menopause among education cat-
egories (low/medium/high).
To test the hypothesis that women who
were older at their last pregnancy less
frequently report hot flashes, age at last
pregnancy was divided into three catego-
ries (<36, 36–39.9, >39.9 years) in both
data sets. Period of breast feeding was
not asked in western Massachusetts. In
Mexico, women older than 35 at their last
birth were further divided into categories
based on the length of breast feeding of
their last child (<12 months, >11.9 months).
Symptom frequency was measured
with the symptom questionnaire devel-
oped and used in Canada, Japan, and
Massachusetts56–58. Symptoms associated
with the menopause (e.g. hot flashes) are
embedded in a list of everyday com-
plaints59. The introductory question reads,
»Thinking back over the past two weeks,
have you been bothered by any of the fol-
lowing?« Chi-square analyses were ap-
plied to evaluate symptom differences du-
ring the two weeks prior to interview
(yes/no) in relation to age at last child-
birth (<36, 36–39.9, >39.9 years) and, in
Mexico, length of breast feeding (<12
months, >11.9 months).
HRT use and length of time of HRT
use were queried in both western Massa-
chusetts and Puebla. In addition, women
in Mexico were asked if they had ever
used HRT. Chi-square analyses were ap-
plied to evaluate symptom difference dur-
ing the two weeks prior to interview
(yes/no) in relation to use of HRT at inter-
view (yes/no).
Results
As shown in Table 1, median age at
natural menopause (i.e. hysterectomies
excluded) using probit analysis was 52.5
years in western Massachusetts and 49.7
years in Puebla. In western Massachu-
setts, rate of hysterectomy was 19%. As
shown in Table 2, rates of hysterectomy
differed significantly by level of educa-
tion. Those with the most education (17–
22 years) had the lowest rates of hyster-
ectomy (6%) compared to those with 13–
16 years of education (19%) and those
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with less than 13 years of education (24%,
p<0.05).
In Puebla, rate of hysterectomy was
23%. As in Massachusetts, rates of hys-
terectomy differed significantly by level
of education. However, the direction of
the relationship between hysterectomy
and education was the opposite of that
seen in western Massachusetts. In Mex-
ico, those with the least education (0–6
years) had the lowest rates of hysterec-
tomy (18%) compared to those with 6–12
years of education (29%), and those with
more than 12 years of education (27%,
p<0.01).
Does age at natural menopause differ
by level of education? As Table 2 shows,
in western Massachusetts mean ages at
menopause did not differ in relation to
levels of education (low 48.9, medium
50.1, high 49.9 years). Of note, 25 of 75
post-menopausal women who returned
their questionnaires were excluded from
the analyses due to a history of hysterec-
tomy and these exclusions were not ran-
domly distributed in relation to category
of education level – eight were excluded
from the category of low education (50%
of post-menopausal women), 14 from the
middle (38%), and three from the highest
(14%).
Similarly, in Puebla, mean age at nat-
ural menopause did not vary by level of
education (low 47.5, middle 47.6, high
47.7). Those excluded from analyses due
to hysterectomies numbered 160 of 426
post-menopausal women – 63 from the
category of low education (31% of post-
menopausal women), 78 from the middle
(49%), and 19 from the highest (44%). As
in Massachusetts, the exclusion from
analyses was not random in relation to
level of education.
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Mean age (yrs.) 50.0 (6.3) 49.1 (5.6)
Mean level of education (yrs.) 8.1 (4.4) 15.2 (2.5)1
Employed outside of the home 63% 84%1
Marital status 66% married 53% married1
13% single 17% single
11% widowed 2% widowed
10% other 28% other
Mean number of live births 3.6 (2.3) 2.0 (1.4)1
Frequency of hysterectomy 174/755 (23.0%) 65/349 (18.7%)
Mean age at hysterectomy 41.8 (6.2) 42.3 (7.2)
(range 25–58) (range 26–57)
Naturally post-menopausal 277/755 75/349
Mean recalled age at natural 47.6 (3.8) 49.6 (3.4)
menopause (yrs.) (range 40–58) (range 41–57)
Median age at natural menopause (yrs.) 49.7 (range 49.2–50–3) 52.5 (range 51.6–53.7)
(probit analysis) range limit 40–60 range limit 40–60
1 completed surveys: N=257
In western Massachusetts, frequency
of hot flashes during the two weeks prior
to interview was 32%. Women with hot
flashes were older (50.2 vs. 48.8 years,
p<0.05) and more likely to be post-meno-
pausal (p<0.05). They did not differ by
number of children. In Puebla, rate of hot
flashes during the two weeks prior to in-
terview was 49.6%. Women with hot fla-
shes were older (50.6 vs. 49.4 years,
p=0.01); were more likely to be post-me-
nopausal, (p<0.01); and had more chil-
dren (3.8 vs. 3.4, p=0.01). Did women
with a history of late childbearing have
fewer hot flashes? This question was one
of the original hypotheses of the Mexico
study, before the investigators encoun-
tered the high incidence of tubal ligation.
In Massachusetts, rate of tubal liga-
tion was 30% (see Table 3), with an aver-
age age at tubal ligation of 33.9 years
(SD=4.8, range 23–44). Average age at
first birth was 25.4 years (SD=5.2, range
14.4–41.0) and average age at last birth
was 30.5 years (SD=5.5, range 16.5–44,
n=199). Of the 199 mothers, 32 (16%) re-
ported a last birth within the ages of 36.0
and 39.9, seven (4%) reported a last birth
at the age of 40 or older. Because of the
low number of births among women of
older ages, it is difficult to adequately
test the hypothesis that late childbearing
is associated with a lower symptom fre-
quency. As Table 4 demonstrates, there
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TABLE 2








Low (8–12 yrs.) 24% 8 48.9 (2.9) 8
Medium (13–16 yrs.) 19% 14 50.1 (3.5) 23
High (17–22 yrs.) 6% 3 49.9 (3.9) 19
p<0.01
Puebla (Mexico)
Low (0–6 yrs.) 18% 63 47.5 (3.7) 140
Medium (7–12 yrs.) 29% 78 47.6 (4.0) 81
High (13–25 yrs.) 27% 19 47.7 (3.8) 24
p<0.05
TABLE 3
FREQUENCY OF WOMEN EVER TO HAVE

















1 Includes »esposo cuida« (coitus interruptus),
foam, Ovulos (vaginal suppositories), douche,
hysterectomy, and tea
were no significant differences in symp-
tom frequency, even though women who
gave birth after 39 years of age were al-
most twice as likely to complain of back
pain. The symptoms associated with a de-
cline in estrogen (cold sweats, hot flashes,
and vaginal dryness) were less frequently
reported among women with births after
39. However, as noted, the sample size
(seven) is extremely small.
In Puebla, 42.5% of participants re-
ported sterilization by tubal ligation,
with an average age of tubal ligation of
32.9 years (SD=5.4, range 18–50). Aver-
age age at first birth was 22.7 years (SD=
5.0, range 11.4–41.6) and average age at
last birth was 30.9 years (SD=5.7, range
16.0–46.6, n=697). Of the 697 mothers, 93
(13%) reported a last birth from 36.0–
39.9 years, 43 (6%) reported a last birth
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TABLE 4
PERCENT OF WOMEN REPORTING A SYMPTOM DURING THE TWO WEEKS PRIOR TO
INTERVIEW IN RELATION TO AGE AT LAST CHILDBIRTH
Western Massachusetts Puebla (Mexico)
Age at last birth <36 36–39.9 >39.9 <36 36–39.9 >39.9
N 156 31 7 561 93 43
Feeling blue (%) 38 42 43 52 54 63
Back pain (%) 47 47 86 57 48 63
Cold sweats (%) 11 10 0 32 28 33
Joint aches (%) 65 58 71 56 59 56
Hot flashes (%) 33 35 29 50 54 56
Trouble sleeping (%) 49 61 57 50 59 56
Nervousness (%) 46 42 57 65 71 79
Vaginal dryness (%) 24 29 0 21 25 30
TABLE 5
PERCENT OF WOMEN REPORTING A SYMPTOM DURING THE TWO WEEKS PRIOR TO
INTERVIEW IN RELATION TO USE OF HRT AT INTERVIEW
Western Massachusetts Puebla (Mexico)
Use HRT Yes No Yes No
N 66 185 88 663
Feeling blue (%) 36 39 57 52
Back pain (%) 44 49 63 55
Cold sweats (%) 6 12 31 31
Joint aches (%) 61 64 60 55
Hot flashes (%) 34 31 67 47**
Trouble sleeping (%) 49 49 56 52
Nervousness (%) 37 52* 72 66
Vaginal dryness (%) 28 21 31 21*
* p<0.05; ** p<0.01
at the age of 40 or older. Symptom fre-
quency did not significantly vary in rela-
tion to age at last birth, although older
mothers more frequently reported six of
the eight symptoms listed in Table 4, in-
cluding hot flashes.
In Puebla, women nursed their last
child for an average of 7.2 months (SD=
8.0, range 0–96). Women with a last birth
at 35 years or later, who breast fed their
last child for 12 months or longer, were
just as likely to report hot flashes (53%)
during the two weeks prior to interview
than were those women who had given
birth to their last child prior to age 35 or
who did not breast feed for an entire year
(51%).
In Massachusetts, 28.5% of partici-
pants were using HRT at time of inter-
view. Among users, HRT had been taken
for an average of 4.0 years (SD=4.9, range
0.01–23 years). Eight percent had been
using HRT for less than one year. As Ta-
ble 5 shows, women using HRT were less
likely to report nervousness (p<0.05), but
there were no differences in reported fre-
quency of hot flashes or vaginal dryness.
In Mexico, 11.7% were using HRT at
time of interview; 24.9% had ever used
HRT for an average of 1.8 years (SD=3.0).
Among those using HRT at time of inter-
view, 41% had been using HRT for less
than one year. Surprisingly, women using
HRT were more likely to report hot fla-
shes (p<0.01) and vaginal dryness (p<0.05)
compared to women not using HRT.
Discussion
Certainly more could be written about
variation in age and symptom experience
at menopause within and between these
two populations. However, the purpose of
this paper was to consider how the medi-
cal management of female fertility affects
studies of menopause. Very briefly, hys-
terectomies reduce sample sizes in a non-
random way, tubal ligations bring about a
permanent end to fertility well before the
age of natural menopause, and HRT has
the potential to affect survey results for
symptom frequencies.
It is not the purpose of this paper to
oppose medical care in instances where
hysterectomies save lives, where tubal li-
gations are the best choice for fertility
control, and where the use of HRT allows
women beset by hot flashes to sleep
through the night. However, it is impor-
tant to point out that there is a medical
culture that, with women's cooperation20,47,
considers the post-reproductive uterus to
be unnecessary and encourages hysterec-
tomies for conditions that could be treated
with less invasive measures. In addition,
this medical culture provides permanent
sterilization for women in countries where
other options are less available or less ef-
fective due to political, economic, or cul-
tural constraints14. This same medical
culture also supports the widespread use
of HRT, although recent studies have
challenged the safety and necessity of
HRT60–62.
Female biology, more so than male bi-
ology, is aggressively »treated« by medi-
cine47,63. Hysterectomies, most methods
of birth control, and the use of HRT are
part of a larger context of biomedicine's
attention to female bodies and, it is im-
portant to point out, these treatments are
interconnected. A history of tubal ligation
increases the risk of hysterectomy42,43, a
history of hysterectomy increases the use
of HRT22,30,52. Relatedly, the use of estro-
gen replacement therapy (ERT) in coun-
tries such as Finland increases the risk of
hysterectomies64, as it did in the United
States prior to the use of HRT (estrogen
in combination with progestin)65.
Another aspect of medicalization, men-
tioned briefly in the Methods section, is
the arbitrary division between meno-
pause (after age 39) and premature ovar-
ian failure (before age 40). This division
between normality and pathology breaks
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apart the study of the continuum of re-
productive senescence. Additionally, this
division may not be equally valid in all
populations, particularly in populations
such as Mexico where the average age of
natural menopause is relatively young.
This division between menopause and
premature ovarian failure truncates the
left side of the sample, inflates the aver-
age age at menopause, and places con-
straints on some interesting questions
having to do with age at menopause as an
aspect of human variation.
In relation to age at menopause and
level of education, did the nonrandom ex-
clusion of study participants due to hys-
terectomies mask significant differences
that might exist? Probably not. Within
the education categories, the exclusion of
women by hysterectomy was most likely
random. Both samples were relatively ho-
mogeneous. The western Massachusetts
sample was >95% non-Hispanic white. In
Puebla, only 3% of the sample spoke an
indigenous dialect. Therefore, there were
few population differences to consider
when explaining hysterectomy risk wi-
thin education levels. Nonetheless, had
there been significant differences be-
tween education categories in mean ages
at menopause, this difference, combined
with a disproportionate number of hys-
terectomies, could affect the overall sam-
ple mean age at menopause. In general,
women with hysterectomies are excluded
from studies of age at menopause as if
hysterectomies were random39; however,
hysterectomies are not random and this
can affect study results.
In agreement with other studies42,43,
women in western Massachusetts who
underwent a tubal ligation were more
likely to undergo a hysterectomy com-
pared to women who had not undergone a
tubal ligation (17% vs. 13%, ns). How-
ever, the opposite was true in Mexico,
where only 20% of women who under-
went a hysterectomy had undergone a
tubal ligation compared to 26% who ne-
ver had a tubal ligation. It is not unrea-
sonable to propose that, in the case of
Mexico, women used hysterectomies as a
form of birth control instead of tubal liga-
tion. One participant did give »hysterec-
tomy« as a form of birth control in her in-
terview (Table 3).
With respect to symptom experience
at menopause and age at last childbirth,
Lancaster and Lancaster66 observed that
hunting-gathering mothers often gave
birth to their last child in their late thir-
ties or early forties. This birth was often
followed by a long period of lactation last-
ing from four to nine years. Often, men-
strual cycling never resumed. »The long
lactation period for the last child of a
hunter-gatherer mother may have impor-
tant effects in regulating or masking
some of the more unpleasant symptoms
of menopause reported by modern wo-
men« (p.49). Later, Lancaster and King51
were more specific, arguing that »for ma-
ny women in time past menopause oc-
curred within the hormonal context of
lactation. Unpleasant symptoms caused
by abrupt fluctuations in circulating hor-
mones may have been masked or regu-
lated by the continuous presence of pro-
lactin and oxytocin« (p.12).
In considering a relationship between
breast feeding and hot flashes among
women in Puebla, it was hypothesized
that late pregnancy and long lactation
would be associated with fewer hot fla-
shes. However, only 7% of women gave
birth after the age of 39. One reason for
this was a tubal ligation rate of 43%, with
a mean age at tubal ligation of 32.9 years
(SD=5.4 years). In other words, this sam-
ple of urban women drawn from the city
of Puebla did not allow for the testing of
the hypothesis formulated by Lancaster
and King with respect to »women in time
past«51.
Finally, symptom frequency in rela-
tion to the use of HRT demonstrated so-
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me surprising results. Women take HRT
to relieve immediate short-term physical
or emotional symptoms, including hot fla-
shes18,54, therefore it was expected that
women taking HRT would report fewer
symptoms. However, in western Massa-
chusetts, only nervousness was decrea-
sed among women taking HRT. In Pue-
bla, women taking HRT at interview
were more likely to report hot flashes
compared to those who were not taking
HRT (67 vs. 47%, ns). It may be that
women did not answer the question with
respect to the two weeks prior to inter-
view, but instead treated the question as
»Have you ever had hot flashes?« Alterna-
tively, since so many of the women in
Puebla were new to the use of HRT (41%),
perhaps the treatment was not yet ad-
justed to reduce symptom frequency.
The medical management of meno-
pause by HRT is promoted through the
popular media18, self-help books28, epide-
miology, medical journals, advertising23,
professional medical societies, the medi-
cal profession and a pharmaceutical in-
dustry beholden to global markets, prof-
its, and corporate stocks29. The result of
this promotion of HRT is the creation of a
mind set in which menopause is linked
not only to an option but also to an obliga-
tion to prescribe HRT29. However, women
themselves are active consumers and
have a role to play in limiting the me-
dicalization of their lives20. In Puebla, for
example, women have embraced the use
of tubal ligations as a way to limit family
size. In contrast, more than half of these
women who had tried HRT stopped using
it. In the United States, recent evidence
for the deleterious effects associated with
prolonged use of HRT60–62 has resulted in
a drop in HRT sales67. In other words, the
medicalization of reproductive aging is a
dynamic process, not a steady state.
While investigators do debate the ex-
clusion or inclusion of hysterectomies in
computing median ages at menopau-
se68,69, human biologists who study meno-
pause have less frequently been explicit
about the effects of tubal ligations and
HRT on study results. The goal of this pa-
per was not to bemoan medical advances,
but to call attention to how medicine, as
an aspect of culture, can affect studies of
menopausal biology.
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MEDIKALIZACIJA @ENSKE PLODNOSTI – NEKI PUTOKAZI ZA
STUDIJ MENOPAUZE
S A @ E T A K
Ovaj rad ilustrira potrebu humanih biologa da se u istra`ivanjima reproduktivnog
starenja ~ovjeka u obzir uzmu dalekose`ni utjecaji biomedicine. Prikazani su podaci iz
zapadnog Massachusettsa (SAD) te iz Puebla (Meksiko), kako bi se ilustrirali u~inci
stopa histerektomije, podvezivanja jajovoda te hormonalne nadomjesne terapije na
studije dobi menopauze i simptoma koji se do`ivljavaju prilikom perioda menopauze.
Prvo, u istra`ivanju dobi prirodne menopauze u odnosu na razinu obrazovanja, podaci
su poravnani u odnosu na neslu~ajnost uzorka prouzrokovanu isklju~ivanjem histerek-
tomiziranih `ena (uz stopu koja je specifi~na za odre|enu zemlju). Drugo, prilikom is-
tra`ivanja u~estalosti simptoma u odnosu na trudno}e u kasnijoj dobi, veli~ine uzorka
bile su vrlo male, dijelom i zbog visoke u~estalosti podvezivanja jajovoda (43%) u Pue-
bla (Meksiko). Kona~no, u~estalost »valunga« tijekom dva tjedna prije intervjua, neo~e-
kivano, nije bila ni`e me|u `enama koje su koristile hormonalno zamjensko lije~enje.
Humani biolozi koji istra`uju biolo{ki proces reproduktivnog starenje moraju tako|er
posvetiti pa`nju i kulturalnim utjecajima biomedicine.
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